Lacticaseibacillus rhamnosus Probio-M9 enhanced the antitumor response to anti-PD-1 therapy by modulating intestinal metabolitesResearch in context

Summary: Background: Probiotics have been increasingly proposed for enhancing immune checkpoint blockade (ICB) treatments against cancer. However, its causal relationship with immunotherapeutic efficacy remains unclear, which promoted us to explore if and how probiotic Lacticaseibacillus rhamnosus...

Повний опис

Бібліографічні деталі

Автори:	Guangqi Gao, Siyuan Shen, Tao Zhang, Jiachao Zhang, Shi Huang, Zhihong Sun, Heping Zhang
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Elsevier 2023-05-01
Серія:	EBioMedicine
Предмети:	Gut microbiota Anti-PD-1 Probiotics Lacticaseibacillus rhamnosus Probio-M9 α-ketoglutaric acid Synergistic anti-tumor therapeutics
Онлайн доступ:	http://www.sciencedirect.com/science/article/pii/S2352396423000981
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!